68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
Abstract Background 68Ga-labelled prostate specific membrane antigen (PSMA) ligand PET/CT is a promising modality in primary staging (PS) and biochemical relapse (BCR) of prostate cancer (PC). However, pelvic nodes or local recurrences can be difficult to differentiate from radioactive urine. CT uro...
|Main Authors:||, , , , , ,|